CV Sciences, Inc. (CVSI) stock
CVSIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-21.13%)
Close on Oct 19, 2026Market cap $2.53MP/E –Yield –
CV Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
CV Sciences's operating cash flow for the twelve months ending Sep 30, 2026 was -$170.00K. For fiscal 2025 it was -$407.00K. The highest annual figure on record is $12.56M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$407.00K | – |
| FY2024 | Dec 31, 2024 | -$861.00K | -138.2% |
| FY2023 | Dec 31, 2023 | $2.25M | – |
| FY2022 | Dec 31, 2022 | -$1.89M | – |
| FY2021 | Dec 31, 2021 | -$7.49M | – |
| FY2020 | Dec 31, 2020 | -$7.30M | – |
| FY2019 | Dec 31, 2019 | -$2.23M | -117.7% |
| FY2018 | Dec 31, 2018 | $12.56M | +247.4% |
| FY2017 | Dec 31, 2017 | $3.62M | – |
| FY2016 | Dec 31, 2016 | -$2.05M | – |
| FY2015 | Dec 31, 2015 | -$4.21M | – |
| FY2014 | Dec 31, 2014 | -$6.71M | – |
| FY2013 | Dec 31, 2013 | -$4.88M | – |
| FY2012 | Dec 31, 2012 | -$64.08K | – |
| FY2011 | Dec 31, 2011 | -$79.63K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $63.00K | – |
| Q2 FY2026 | Jun 30, 2026 | $20.00K | -93.0% |
| Q1 FY2026 | Mar 31, 2026 | $101.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$354.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$259.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $287.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$81.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$164.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$122.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$57.00K | -104.0% |
| Q1 FY2024 | Mar 31, 2024 | -$518.00K | -153.1% |
| Q4 FY2023 | Dec 31, 2023 | -$114.00K | -154.3% |
| Q3 FY2023 | Sep 30, 2023 | -$19.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $1.41M | – |
| Q1 FY2023 | Mar 31, 2023 | $975.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $210.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$547.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.17M | – |
| Q1 FY2022 | Mar 31, 2022 | -$379.00K | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.16M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.57M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.06M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.69M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.47M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.73M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.41M | -189.5% |
| Q1 FY2020 | Mar 31, 2020 | -$1.69M | -322.2% |
| Q4 FY2019 | Dec 31, 2019 | -$4.63M | -275.7% |
| Q3 FY2019 | Sep 30, 2019 | -$1.06M | -123.2% |
| Q2 FY2019 | Jun 30, 2019 | $2.70M | -27.4% |
| Q1 FY2019 | Mar 31, 2019 | $761.00K | -54.0% |
| Q4 FY2018 | Dec 31, 2018 | $2.63M | -11.3% |
| Q3 FY2018 | Sep 30, 2018 | $4.56M | +928.8% |
| Q2 FY2018 | Jun 30, 2018 | $3.72M | +1979.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.65M | +6364.2% |
| Q4 FY2017 | Dec 31, 2017 | $2.97M | – |
| Q3 FY2017 | Sep 30, 2017 | $442.94K | – |
| Q2 FY2017 | Jun 30, 2017 | $178.69K | – |
| Q1 FY2017 | Mar 31, 2017 | $25.59K | – |
| Q4 FY2016 | Dec 31, 2016 | -$624.46K | – |
See a number that looks wrong?